Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Net Income towards Common Stockholders (2022 - 2025)

Historic Net Income towards Common Stockholders for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to -$10.4 million.

  • Lucid Diagnostics' Net Income towards Common Stockholders rose 1595.67% to -$10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$65.8 million, marking a year-over-year decrease of 2586.31%. This contributed to the annual value of -$53.0 million for FY2024, which is 68.17% down from last year.
  • Per Lucid Diagnostics' latest filing, its Net Income towards Common Stockholders stood at -$10.4 million for Q3 2025, which was up 1595.67% from -$7.9 million recorded in Q2 2025.
  • Lucid Diagnostics' 5-year Net Income towards Common Stockholders high stood at -$7.9 million for Q2 2025, and its period low was -$36.0 million during Q1 2025.
  • Over the past 4 years, Lucid Diagnostics' median Net Income towards Common Stockholders value was -$12.4 million (recorded in 2024), while the average stood at -$14.4 million.
  • Examining YoY changes over the last 5 years, Lucid Diagnostics' Net Income towards Common Stockholders showed a top increase of 2832.35% in 2025 and a maximum decrease of 9890.66% in 2025.
  • Over the past 4 years, Lucid Diagnostics' Net Income towards Common Stockholders (Quarter) stood at -$14.9 million in 2022, then grew by 27.45% to -$10.8 million in 2023, then dropped by 6.57% to -$11.5 million in 2024, then increased by 9.91% to -$10.4 million in 2025.
  • Its Net Income towards Common Stockholders was -$10.4 million in Q3 2025, compared to -$7.9 million in Q2 2025 and -$36.0 million in Q1 2025.